MedDataX Logo

Individual Differences in Diabetes Risk: Role of Slow WaveSleep

NCT ID: NCT00989378

Last Updated: 2013-09-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

5 participants

Study Classification

OBSERVATIONAL

Study Start Date

2008-11-30

Study Completion Date

2010-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study will examine the relationship between the amount of slow wave sleep (deep sleep) and the ability of the body to bring the blood sugar level to a normal range after receiving glucose.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Sleep Diabetes

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

sleep insulin diabetes determine association between sleep characteristics and diabetes risk

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

control

normal healthy men and women

baseline study

Intervention Type BEHAVIORAL

normal bedtimes

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

baseline study

normal bedtimes

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* healthy volunteers age 18-20 with a BMI \< 27kg/m2 in women and \< 28 kg/m2 in men with normal findings on clinical examination, routine laboratory tests and EKG
* only subjects who have regular life styles (no shift work, no travel across time zone during the previous 4 weeks)
* habitual bedtimes between 7.0-8.5 hours/night
* do not take medications will be recruited

Exclusion Criteria

* women taking hormonal contraceptive therapy and pregnant women will be excluded
* individuals with a history of psychiatric, endocrine, cardiac or sleep disorders will be excluded
Minimum Eligible Age

18 Years

Maximum Eligible Age

20 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Chicago

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Eve Van Cauter, Ph.D.

Role: PRINCIPAL_INVESTIGATOR

University of Chicago

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Chicago

Chicago, Illinois, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

16026A

Identifier Type: -

Identifier Source: org_study_id